| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/26/2008 | EP1901737A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone |
| 03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | CN101147793A Method for preparing traditional Chinese medicine for treating urinary system diseases |
| 03/26/2008 | CN101147771A New woman diseases preparation and its preparation process |
| 03/26/2008 | CN101147729A Tamsulosin hydrochloride cotrolled-releasing tablet preparation and preparing method thereof |
| 03/26/2008 | CN100376598C Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | CA2432432C Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 03/25/2008 | CA2371178C Prucalopride oral solution |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/20/2008 | WO2008034011A2 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 03/20/2008 | WO2008033513A1 ISOXAZOLINE ALPHA 1a/1d ADRENORECEPTOR ANTAGONISTS |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032054A2 Composite material comprising a tissue matrix compound and a bioactive glass |
| 03/20/2008 | WO2007141661A3 Herbal compositions for the prevention or treatment of benign prostatic hyperplasia |
| 03/20/2008 | WO2007125385A3 Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070934 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070862 Methods using glycosaminoglycans for the treatment of nephropathy |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/19/2008 | EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | CN101143239A Medicinal controlled release catheter |
| 03/19/2008 | CN101143206A Traditional Chinese medicine for treating acute glomerulonephritis of baby |
| 03/19/2008 | CN101143204A Medicinal composition for treating chronic nephritis and its preparing process |
| 03/19/2008 | CN101143186A New jinxiang preparation for treating male and female pelvic inflammation and production method thereof |
| 03/19/2008 | CN101143175A New jinji preparation for treating male and female pelvic inflammation and production method thereof |
| 03/19/2008 | CN101143160A Kidney tea extract and its preparing process and application |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | CA2298493C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
| 03/18/2008 | CA2288705C Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/13/2008 | WO2008030638A2 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2007116428A3 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis |
| 03/13/2008 | WO2007082914A3 Method of diagnosis and method of treatment |
| 03/13/2008 | WO2007073505A3 Trpa1 inhibitors for treating pain |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3 |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080063640 Pin-Prc Transition Genes |
| 03/13/2008 | US20080063601 treatment of urogenital disorders comprising administering calcium channel blockers, such as triptolide, prodrugs and/or derivatives |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897880A1 1,3-benzothiazinone derivative and use thereof |
| 03/12/2008 | EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 03/12/2008 | EP1613596B1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
| 03/12/2008 | EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 03/12/2008 | CN101142203A Novel coumarin derivatives as ion channel openers |
| 03/12/2008 | CN101141964A Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 03/12/2008 | CN101138623A Medicament for preventing and treating deficiency of the kidney essence |
| 03/12/2008 | CN101138582A Use of compound red sage root tablet for producing medicine for preventing and treating diabetes chronic complication |
| 03/12/2008 | CN101138581A Traditional chinese medicine preparation for treating urinary system infection contamination and method of preparing the same |
| 03/12/2008 | CN101138568A Application of hydrochloric acid in the preparation of medicament for treating diabetes and prostate gland disease |
| 03/12/2008 | CN100374441C 2-substituted benzyl-5,7-dihydrocarbyl-3,7-dihydro pyrroline [2,3-d] pyromidine-4-one derivative ,its preparation and medicinal use |
| 03/12/2008 | CN100374124C Medicine for dispelling dampness, removing stone and apocatastasis, and its prepn. method |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7341724 Apoptosis of rectum and prostate gland cancer |
| 03/11/2008 | CA2413087C Suplatast tosilate crystals |
| 03/11/2008 | CA2203372C Human scf, a splice variant thereof, its pharmaceutical use |
| 03/11/2008 | CA2195425C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026298A1 Remedy for kidney disease |
| 03/06/2008 | WO2008006795A3 Indole compounds |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate |
| 03/06/2008 | US20080058329 Novel indane compounds |
| 03/06/2008 | US20080058328 Substituted 4-phenyltetrahydroisoquinolines, pharmaceuitcal compositions comprising them and therapeutic methods for their use |